EC: 1.1.1.105
all-trans-retinol dehydrogenase (NAD+) (all-trans retinol:NAD+ oxidoreductase)
Pathways
| pathway id | name |
|---|---|
| BioCyc:HUMAN_PWY-6872 | retinoate biosynthesis I |
| BioCyc:HUMAN_PWY66-401 | superpathway of tryptophan utilization |
| BioCyc:META_PWY-6872 | retinoate biosynthesis I |
| BioCyc:META_PWY66-21 | ethanol degradation II |
| BioCyc:META_PWY-6313 | serotonin degradation |
| BioCyc:META_PWY-6342 | noradrenaline and adrenaline degradation |
| BioCyc:META_PWY-6861 | the visual cycle I (vertebrates) |
| BioCyc:HUMAN_PWY-5451 | acetone degradation I (to methylglyoxal) |
| BioCyc:HUMAN_PWY66-21 | ethanol degradation II |
| BioCyc:META_PWY-6857 | retinol biosynthesis |
| BioCyc:MOUSE_PWY66-21 | ethanol degradation II (cytosol) |
| BioCyc:HUMAN_PWY-6857 | retinol biosynthesis |
| BioCyc:HUMAN_PWY-6313 | serotonin degradation |
| BioCyc:META_PWY-7466 | acetone degradation III (to propane-1,2-diol) |
| BioCyc:HUMAN_PWY-6342 | noradrenaline and adrenaline degradation |
| BioCyc:HUMAN_PWY-6861 | the visual cycle I (vertebrates) |
| BioCyc:META_PWY-5451 | acetone degradation I (to methylglyoxal) |
| BioCyc:MOUSE_PWY-5079 | phenylalanine degradation III |
| Reactome:R-HSA-211859 | Biological oxidations |
| Reactome:R-HSA-5362517 | Signaling by Retinoic Acid |
| Reactome:R-MMU-1430728 | Metabolism |
| Reactome:R-MMU-556833 | Metabolism of lipids |
| Reactome:R-MMU-211859 | Biological oxidations |
| Reactome:R-MMU-162582 | Signaling Pathways |
| Reactome:R-RNO-211945 | Phase I - Functionalization of compounds |
| Reactome:R-RNO-71384 | Ethanol oxidation |
| Reactome:R-RNO-162582 | Signaling Pathways |
| Reactome:R-RNO-9006931 | Signaling by Nuclear Receptors |
| Reactome:R-HSA-556833 | Metabolism of lipids |
| Reactome:R-HSA-9006931 | Signaling by Nuclear Receptors |
| Reactome:R-MMU-5365859 | RA biosynthesis pathway |
| Reactome:R-RNO-8964572 | Lipid particle organization |
| Reactome:R-RNO-211859 | Biological oxidations |
| Reactome:R-HSA-211945 | Phase I - Functionalization of compounds |
| Reactome:R-HSA-71384 | Ethanol oxidation |
| Reactome:R-HSA-5365859 | RA biosynthesis pathway |
| Reactome:R-MMU-211945 | Phase I - Functionalization of compounds |
| Reactome:R-MMU-71384 | Ethanol oxidation |
| Reactome:R-MMU-9006931 | Signaling by Nuclear Receptors |
| Reactome:R-RNO-1430728 | Metabolism |
| Reactome:R-RNO-556833 | Metabolism of lipids |
| Reactome:R-RNO-5362517 | Signaling by Retinoic Acid |
| Reactome:R-HSA-1430728 | Metabolism |
| Reactome:R-HSA-8964572 | Lipid particle organization |
| Reactome:R-HSA-162582 | Signaling Pathways |
| Reactome:R-MMU-8964572 | Lipid particle organization |
| Reactome:R-MMU-5362517 | Signaling by Retinoic Acid |
| Reactome:R-RNO-5365859 | RA biosynthesis pathway |
| WikiPathways:WP5188 | Retinol metabolism |
| WikiPathways:WP4524 | Alternative pathway of fetal androgen synthesis |
| PathBank:SMP0000429 | Disulfiram Action Pathway |
| PathBank:SMP0000644 | Celecoxib Metabolism Pathway |
| PathBank:SMP0087353 | Retinol Metabolism |
| PathBank:SMP0120720 | Vitamin A Deficiency |
| PathBank:SMP0000074 | Retinol Metabolism |
| PathBank:SMP0000336 | Vitamin A Deficiency |
| PathBank:SMP0087260 | Retinol Metabolism |
| PathBank:SMP0000449 | Ethanol Degradation |
| PathBank:SMP0000096 | Celecoxib Action Pathway |